News

This startup wants to prove gene-editing embryos is safe for making healthy babies

By Rob Stein, NPR [cites CGS' Katie Hasson] | 09.29.2026

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

Human Genetic Modification

Demographic Fears and Far-Right Fantasies

By Alexandra Minna Stern, Los Angeles Review of Books | 09.26.2026

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

Society

She Got a Great Deal on Egg Freezing. Then She Spiraled

By Maia Hibbett, Wired | 09.09.2026

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conservatory-trained viola...

U.S. Federal

Eugenics and the Nihilism of Law-and-Order Politics

By Terence Keel, Los Ángeles Review of Books | 09.06.2026

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

U.S. States

GM plants differ from non-GM parents in unintended ways – and that goes for GM gene-edited plants too

By Staff, GMWatch | 03.28.2026

Following a recent podcast interview we were asked whether there is any solid scientific research looking at how gene expression...

Other Countries

Fertility Inc.: The Embryo Editing Dinner

By Ryan Knutson and Emily Glazer, The Journal | 03.27.2026

Genetically engineered babies are banned in the U.S. But that isn’t stopping Silicon Valley tech titans from trying to make...

Bioethics

California-Financed Gene Therapy Scores Historic First Commercial Approval

By David Jensen, The California Stem Cell Report | 03.26.2026

SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it...

Genomics

Eugenics and the Modern Synthesis, Part II

By Jessica Riskin, Los Ángeles Review of Books | 03.24.2026

This is the second part of the 14th installment in the Legacies of Eugenics series, which features essays by...

Bioethics

The potential loophole in Trump’s plan to get other countries to pay more for drugs

By John Wilkerson, Stat | 03.24.2026

^{"Donald Trump speaking with supporters at a campaign rally at the South Point Arena in Las Vegas, Nevada"...}

Animal Biotechnologies

Q&A: Embryo editing entrepreneur Cathy Tie closes one startup and begins another in biology’s most taboo frontier

By Ryan Cross, Endpoints News | 03.24.2026

Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of...

Genetic Selection

Eugenics and the Modern Synthesis, Part I

By Jessica Riskin, Los Ángeles Review of Books | 03.23.2026

This is the first part of the 14th installment in the Legacies of Eugenics series, which features essays by leading...

Civil Society

A Billionaire-Backed Startup Wants to Grow 'Organ Sacks' to Replace Animal Testing

By Emily Mullin, Wired | 03.23.2026

As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a...

Human Genetic Modification